Gene · 17
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of chimeric antigen receptor macrophages from human pluripotent stem cells to target glioblastoma. | Immunooncol Technol | 2023 | 38192614 | PubTator, text mining | PubMed |
| Transgenic rodents as dynamic models for the study of respiratory rhythm generation and modulation: a scoping review and a bibliometric analysis. | Front Physiol | 2023 | 38179140 | PubTator, text mining | PubMed |
| Genome-wide CRISPRi Screen in Human iNeurons to Identify Novel Focal Cortical Dysplasia Genes. | bioRxiv | 2023 | 38168415 | PubTator, text mining | PubMed |
| E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis. | Front Toxicol | 2023 | 38164438 | PubTator, text mining | PubMed |
| RENGE infers gene regulatory networks using time-series single-cell RNA-seq data with CRISPR perturbations. | Commun Biol | 2023 | 38155269 | PubTator, text mining | PubMed |
| Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse". | Int J Mol Sci | 2023 | 38139149 | PubTator, text mining | PubMed |
| Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy. | Biomedicines | 2023 | 38137554 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease. | Cells | 2023 | 38132179 | PubTator, text mining | PubMed |
| Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice. | Mol Ther Methods Clin Dev | 2023 | 38107675 | PubTator, text mining | PubMed |
| The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation. | Cancer Cell Int | 2023 | 38105188 | PubTator, text mining | PubMed |
| PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution. | Nat Commun | 2023 | 38102136 | PubTator, text mining | PubMed |
| Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective. | J Nanobiotechnology | 2023 | 38087359 | PubTator, text mining | PubMed |
| Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression. | Sci Rep | 2023 | 38081875 | PubTator, text mining | PubMed |
| Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model. | Transl Neurodegener | 2023 | 38049923 | PubTator, text mining | PubMed |
| CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells. | iScience | 2023 | 38034357 | PubTator, text mining | PubMed |
| FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. | Cancer Res Commun | 2023 | 38032106 | PubTator, text mining | PubMed |
| Generation of hepatitis C virus-resistant liver cells by genome editing-mediated stable expression of RNA aptamer. | Mol Ther Methods Clin Dev | 2023 | 38027068 | PubTator, text mining | PubMed |
| Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions. | bioRxiv | 2023 | 38014352 | PubTator, text mining | PubMed |
| Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair. | Cell Biosci | 2023 | 38007480 | PubTator, text mining | PubMed |
| Horizontal acquisition of a DNA ligase improves DNA damage tolerance in eukaryotes. | Nat Commun | 2023 | 37993452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/17/papers?page=4